NEPT - ネプチュ―ン・テクノロジ―ズ・アンド・バイオリソ―シズ (Neptune Wellness Solutions Inc.)

NEPTのニュース

   Earnings Preview: Neptune Technologies (NEPT) Q4 Earnings Expected to Decline  2020/06/03 16:30:07 Zacks Investment Research
Neptune Tech (NEPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   Neptune Technologies (NEPT) Reports Break-Even Earnings for Q3  2020/02/13 12:45:04 Zacks Investment Research
Neptune Tech (NEPT) delivered earnings and revenue surprises of 100.00% and -2.78%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
   The Week In Cannabis: Stocks Fall On Poor Earnings, More Americans Support Legalization  2019/11/15 22:12:28 Benzinga
Two-thirds of Americans say the use of marijuana should be legal, reflecting a considerable surge over the past decade.. Two-thirds of Americans say the use of marijuana should be legal, reflecting a steady increase over the past decade https://t.co/QoMXjiaUYk pic.twitter.com/V4vLqY3r9f — Pew Research Fact Tank (@FactTank) November 14, 2019 GW Pharmaceuticals PLC (NASDAQ: GWPH ) announced two of its medicines have been recommended by the U.K.’s National Institute for Health and Care Excellence to receive routine reimbursement from the National Health Service. Epidiolex, known as Epidyolex in Europe, and Sativex were approved by the NHS for the treatment of epilepsy and multiple sclerosis, respectively. These were probably the most upbeat news items in the cannabis and hemp world this week. The following companies disappointed analysts and investors with their quarterly results and/or guidance (see full coverage for all of these earnings reports in our Cannabis Earnings Portal ): Canopy Growth Corp (NYSE: CGC ) Neptune Wellness Solutions Inc.
   Neptune Wellness Falls On Higher Quarterly Net Loss, Announces Hemp-Derived CBD Deal  2019/11/11 15:41:19 Benzinga Feeds
Neptune Wellness Solutions Inc. (NASDAQ: NEPT ) (TSX: NEPT) reported second-quarter revenue of CA$6.51 million ($4.9 million) on Monday and announced a partnership with International Flavors & Fragrances Inc. (NYSE: IFF ). The second-quarter revenue of CA$6.51 million was lower than the CA$7.07 million in revenue posted in the same period of 2018. The company also posted a quarterly net loss of CA$20.78 million versus a net loss of CA$3.05 million in the corresponding quarter of the prior year. Its adjusted EBITDA was a loss of CA$4.58 million, which is by CA$3.35 million lower than in the second quarter of 2018. Neptune also noted recent milestones such as the acquisition of SugarLeaf assets, which included the CBD consumer brand Forest Remedies; and its entrance into a strategic partnership … Full story available on Benzinga.com
   Neptune Technologies (NEPT) Reports Q2 Loss, Lags Revenue Estimates  2019/11/11 13:25:02 Zacks Investment Research
Neptune Tech (NEPT) delivered earnings and revenue surprises of -325.00% and -23.16%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
   Earnings Preview: Neptune Technologies (NEPT) Q4 Earnings Expected to Decline  2020/06/03 16:30:07 Zacks Investment Research
Neptune Tech (NEPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   Neptune Technologies (NEPT) Reports Break-Even Earnings for Q3  2020/02/13 12:45:04 Zacks Investment Research
Neptune Tech (NEPT) delivered earnings and revenue surprises of 100.00% and -2.78%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
   The Week In Cannabis: Stocks Fall On Poor Earnings, More Americans Support Legalization  2019/11/15 22:12:28 Benzinga
Two-thirds of Americans say the use of marijuana should be legal, reflecting a considerable surge over the past decade.. Two-thirds of Americans say the use of marijuana should be legal, reflecting a steady increase over the past decade https://t.co/QoMXjiaUYk pic.twitter.com/V4vLqY3r9f — Pew Research Fact Tank (@FactTank) November 14, 2019 GW Pharmaceuticals PLC (NASDAQ: GWPH ) announced two of its medicines have been recommended by the U.K.’s National Institute for Health and Care Excellence to receive routine reimbursement from the National Health Service. Epidiolex, known as Epidyolex in Europe, and Sativex were approved by the NHS for the treatment of epilepsy and multiple sclerosis, respectively. These were probably the most upbeat news items in the cannabis and hemp world this week. The following companies disappointed analysts and investors with their quarterly results and/or guidance (see full coverage for all of these earnings reports in our Cannabis Earnings Portal ): Canopy Growth Corp (NYSE: CGC ) Neptune Wellness Solutions Inc.
   Neptune Wellness Falls On Higher Quarterly Net Loss, Announces Hemp-Derived CBD Deal  2019/11/11 15:41:19 Benzinga Feeds
Neptune Wellness Solutions Inc. (NASDAQ: NEPT ) (TSX: NEPT) reported second-quarter revenue of CA$6.51 million ($4.9 million) on Monday and announced a partnership with International Flavors & Fragrances Inc. (NYSE: IFF ). The second-quarter revenue of CA$6.51 million was lower than the CA$7.07 million in revenue posted in the same period of 2018. The company also posted a quarterly net loss of CA$20.78 million versus a net loss of CA$3.05 million in the corresponding quarter of the prior year. Its adjusted EBITDA was a loss of CA$4.58 million, which is by CA$3.35 million lower than in the second quarter of 2018. Neptune also noted recent milestones such as the acquisition of SugarLeaf assets, which included the CBD consumer brand Forest Remedies; and its entrance into a strategic partnership … Full story available on Benzinga.com
   Neptune Technologies (NEPT) Reports Q2 Loss, Lags Revenue Estimates  2019/11/11 13:25:02 Zacks Investment Research
Neptune Tech (NEPT) delivered earnings and revenue surprises of -325.00% and -23.16%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
   Neptune Technologies (NEPT) Reports Break-Even Earnings for Q3  2020/02/13 12:45:04 Zacks Investment Research
Neptune Tech (NEPT) delivered earnings and revenue surprises of 100.00% and -2.78%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
   The Week In Cannabis: Stocks Fall On Poor Earnings, More Americans Support Legalization  2019/11/15 22:12:28 Benzinga
Two-thirds of Americans say the use of marijuana should be legal, reflecting a considerable surge over the past decade.. Two-thirds of Americans say the use of marijuana should be legal, reflecting a steady increase over the past decade https://t.co/QoMXjiaUYk pic.twitter.com/V4vLqY3r9f — Pew Research Fact Tank (@FactTank) November 14, 2019 GW Pharmaceuticals PLC (NASDAQ: GWPH ) announced two of its medicines have been recommended by the U.K.’s National Institute for Health and Care Excellence to receive routine reimbursement from the National Health Service. Epidiolex, known as Epidyolex in Europe, and Sativex were approved by the NHS for the treatment of epilepsy and multiple sclerosis, respectively. These were probably the most upbeat news items in the cannabis and hemp world this week. The following companies disappointed analysts and investors with their quarterly results and/or guidance (see full coverage for all of these earnings reports in our Cannabis Earnings Portal ): Canopy Growth Corp (NYSE: CGC ) Neptune Wellness Solutions Inc.
   Neptune Wellness Falls On Higher Quarterly Net Loss, Announces Hemp-Derived CBD Deal  2019/11/11 15:41:19 Benzinga Feeds
Neptune Wellness Solutions Inc. (NASDAQ: NEPT ) (TSX: NEPT) reported second-quarter revenue of CA$6.51 million ($4.9 million) on Monday and announced a partnership with International Flavors & Fragrances Inc. (NYSE: IFF ). The second-quarter revenue of CA$6.51 million was lower than the CA$7.07 million in revenue posted in the same period of 2018. The company also posted a quarterly net loss of CA$20.78 million versus a net loss of CA$3.05 million in the corresponding quarter of the prior year. Its adjusted EBITDA was a loss of CA$4.58 million, which is by CA$3.35 million lower than in the second quarter of 2018. Neptune also noted recent milestones such as the acquisition of SugarLeaf assets, which included the CBD consumer brand Forest Remedies; and its entrance into a strategic partnership … Full story available on Benzinga.com
   Neptune Technologies (NEPT) Reports Q2 Loss, Lags Revenue Estimates  2019/11/11 13:25:02 Zacks Investment Research
Neptune Tech (NEPT) delivered earnings and revenue surprises of -325.00% and -23.16%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
   Neptune Technologies (NEPT) Reports Q1 Loss, Misses Revenue Estimates  2019/08/14 12:35:03 Zacks Investment Research
Neptune Tech (NEPT) delivered earnings and revenue surprises of -100.00% and -27.72%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

calendar